Biomarin Pharmaceutical (BMRN) Intangibles (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted Intangibles of $4.88 billion for Q2 2026, compared with $239.62 million a year earlier.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Biomarin Pharmaceutical's Intangibles came in at $213.84 million, down 16.2% from FY2024.
- Annual Intangibles has declined for ten consecutive years, with a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- In prior years, Biomarin Pharmaceutical's Intangibles was $255.28 million in FY2024 (-13.4%), $294.7 million in FY2023 (-13.0%), $338.57 million in FY2022 (-12.9%) and $388.65 million in FY2021 (-6.9%).
- The Q2 2026 figure stands as the highest quarterly Intangibles in data going back to Q4 2009.
- The year-over-year decline in Intangibles has ranged between 6.3% (Q2 2022) and 17.3% (Q1 2026) over the last five years.
- According to Business Quant data, Intangibles for the three prior quarters was $204.66 million (Q1 2026), $213.84 million (Q4 2025) and $233.11 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 47.05 Bn |
| 10 | Biomarin Pharmaceutical | 10.64 Bn | 4.51 Bn | 786.91 Mn | 4.88 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.88 Bn |
| Mar 31, 2026 | 204.66 Mn |
| Dec 31, 2025 | 213.84 Mn |
| Sep 30, 2025 | 233.11 Mn |
| Jun 30, 2025 | 239.62 Mn |
| Mar 31, 2025 | 247.35 Mn |
| Dec 31, 2024 | 255.28 Mn |
| Sep 30, 2024 | 260.92 Mn |
| Jun 30, 2024 | 265.53 Mn |
| Mar 31, 2024 | 279.65 Mn |
| Dec 31, 2023 | 294.70 Mn |
| Sep 30, 2023 | 302.48 Mn |
| Jun 30, 2023 | 310.34 Mn |
| Mar 31, 2023 | 325.99 Mn |
| Dec 31, 2022 | 338.57 Mn |
| Sep 30, 2022 | 354.02 Mn |
| Jun 30, 2022 | 369.37 Mn |
| Mar 31, 2022 | 374.25 Mn |
| Dec 31, 2021 | 388.65 Mn |
| Sep 30, 2021 | 388.49 Mn |
API Access
Biomarin Pharmaceutical Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();